pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
The Medicines Co · news · pharmadog
← back to The Medicines Co
News mentioning The Medicines Co
37
stories
7d
Novo gets much-needed lift as Wegovy pill tops Wall Street forecasts
biopharma dive
16d
The molecule was fine. The moment wasn’t.
biopharma dive
20d
Euro Roundup: EMA seeks feedback on platform trials; MHRA to recognize CE-marked devices indefinitely
raps
22d
Most new drugs are still too costly at launch, ICER says
biopharma dive
23d
Should amylin have been obesity therapeutics’ primary target from the start?
biospace
26d
Iambic CEO on taking an AI drug company public
biopharma dive
27d
Euro Roundup: EMA to make ACT EU permanent in 2027
raps
Oct 9, 26
Viatris inks $1.65B Pacira buyout to build non-opioid pain therapy business
biospace
Oct 7, 26
STAT+: In Duchenne muscular dystrophy, a promising therapy is available to a fortunate few
stat
Oct 7, 26
EMA plans major update to pharmacogenomics guideline
raps
Oct 6, 26
The top biopharma conferences in 2027
biopharma dive
Oct 6, 26
MHRA adopts AI framework proposed by UK docs
raps
Oct 6, 26
Recon: BD pledges $19B US investment; McKesson, CD&R to buy Option Care for $5.8B
raps
Oct 1, 26
STAT+: Sanofi, Regeneron expand partnership after Dupixent success
stat
Sep 25, 26
STAT+: Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic
stat
Sep 17, 26
Euro Roundup: MHRA commission makes recommendations on AI regulatory framework in the UK
raps
Sep 15, 26
Stakeholders urge FDA to define data, treatment standards as psychedelic drugs near market
biospace
Sep 10, 26
Novartis shareholder calls for board overhaul following costly deal setbacks: Reuters
fiercebiotech
Sep 2, 26
UK regulator halts sales of Tavneos; UniQure seeks approval for Huntington's gene therapy
endpoints
Aug 27, 26
Euro Roundup: MHRA updates guidance on submitting safety reports for UK products
raps
Aug 26, 26
STAT+: Pharmalittle: We’re reading about a GSK shingles shot, U.S. employers dropping GLP-1 coverage, and more
stat
Aug 19, 26
Enveda’s exercise-simulating obesity tablet clears early clinical test
biospace
Aug 17, 26
Slate uses Fulcrum to vault onto Nasdaq with $245M financing for migraine trials
fiercebiotech
Aug 13, 26
Opinion: How to disrupt the health misinformation business model
stat
Aug 12, 26
Silence cashes in on ‘differentiated’ data; UK reaffirms support for childhood vaccines
biopharma dive
Aug 10, 26
Scribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the masses
biopharma dive
Jul 30, 26
Opinion: Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases
stat
Jul 27, 26
[Podcast] From Protocol to Patient: Inside Clinical Supply with Almac Clinical Services
biopharma dive
Jul 20, 26
MHRA touts uptick in approvals in 2025-2026 annual report
raps
Jul 17, 26
Compounders maintain a firm grip on the GLP-1 market
biopharma dive
← prev
page 1 of 2
next →
